Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jakob Norsk

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Pediatrics|November 23, 2021
Gestational Age and Neonatal ElectrocardiogramsJoachim Hartmann, Maria Munk Pærregaard, Jakob Norsk, et al.
Heart (British Cardiac Society)|December 15, 2015
Functional effects of losartan in hypertrophic cardiomyopathy-a randomised clinical trialAnna Axelsson, Kasper Iversen, Niels Vejlstrup, et al.
The Lancet. Diabetes & Endocrinology|December 24, 2014
Efficacy and safety of the angiotensin II receptor blocker losartan for hypertrophic cardiomyopathy: the INHERIT randomised, double-blind, placebo-controlled trialAnna Axelsson, Kasper Iversen, Niels Vejlstrup, et al.
Microbiology Spectrum|December 15, 2021
Testing Denmark: a Danish Nationwide Surveillance Study of COVID-19Kamille Fogh, Jarl E Strange, Bibi F S S Scharff, et al.
BMC Infectious Diseases|February 11, 2022
Seroprevalence of SARS-CoV-2 antibodies in social housing areas in DenmarkKamille Fogh, Alexandra R R Eriksen, Rasmus B Hasselbalch, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Pediatrics|November 23, 2021
Gestational Age and Neonatal ElectrocardiogramsJoachim Hartmann, Maria Munk Pærregaard, Jakob Norsk, et al.
Heart (British Cardiac Society)|December 15, 2015
Functional effects of losartan in hypertrophic cardiomyopathy-a randomised clinical trialAnna Axelsson, Kasper Iversen, Niels Vejlstrup, et al.
The Lancet. Diabetes & Endocrinology|December 24, 2014
Efficacy and safety of the angiotensin II receptor blocker losartan for hypertrophic cardiomyopathy: the INHERIT randomised, double-blind, placebo-controlled trialAnna Axelsson, Kasper Iversen, Niels Vejlstrup, et al.
Microbiology Spectrum|December 15, 2021
Testing Denmark: a Danish Nationwide Surveillance Study of COVID-19Kamille Fogh, Jarl E Strange, Bibi F S S Scharff, et al.
BMC Infectious Diseases|February 11, 2022
Seroprevalence of SARS-CoV-2 antibodies in social housing areas in DenmarkKamille Fogh, Alexandra R R Eriksen, Rasmus B Hasselbalch, et al.
Pageof 1